Ping An Good Doctor (01833) rose nearly 9% during the trading session. As of the time of writing, the stock was up 7.41%, trading at HK$15.66 with a turnover of HK$267 million. Last month, Morgan Stanley released an in-depth report on Ping An, suggesting that the company is well-positioned to capture key growth opportunities in the areas of resident wealth management, healthcare, and elderly care. The report highlighted Ping An Good Doctor as a crucial anchor in this "value reassessment." As the strategic healthcare and elderly care services segment within the Ping An ecosystem, it synergizes with the comprehensive financial services business to build a Chinese version of the HMO health management model, thereby creating a differentiated advantage. It is understood that UnitedHealth Group in the United States has validated the commercial power of the HMO (Health Maintenance Organization) model over half a century. Ping An Good Doctor's adaptation of this model is not a simple replication but a restructuring into an "Upgraded Optum Version" tailored to the characteristics of the Chinese market. While sharing the same core logic of "deeply integrating payment and services" and shifting from "post-event reimbursement" to "full-cycle health management," Ping An Good Doctor leverages the Ping An Group's "Comprehensive Finance + Healthcare and Elderly Care" strategy to build a more locally adapted service network described as "online, in-hospital, in-enterprise, and at-home." This network precisely addresses pain points such as uneven distribution of medical resources and an accelerating aging population.